Article Versions Notes

Soraluce A, Barrasa H, Asín-Prieto E, Sánchez-Izquierdo JÁ, Maynar J, Isla A, Rodríguez-Gascón A. Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation. Pharmaceutics. 2020; 12(1):54. https://doi.org/10.3390/pharmaceutics12010054

Soraluce, Amaia, Helena Barrasa, Eduardo Asín-Prieto, Jose Ángel Sánchez-Izquierdo, Javier Maynar, Arantxazu Isla, and Alicia Rodríguez-Gascón. 2020. "Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation" Pharmaceutics 12, no. 1: 54. https://doi.org/10.3390/pharmaceutics12010054

Soraluce, A., Barrasa, H., Asín-Prieto, E., Sánchez-Izquierdo, J. Á., Maynar, J., Isla, A., & Rodríguez-Gascón, A. (2020). Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation. Pharmaceutics, 12(1), 54. https://doi.org/10.3390/pharmaceutics12010054